Tag:
Novo Nordisk
Latest Headlines
Latest Headlines
Hospitals should cut down off-label use of hemophilia drug
Researchers caution against off-label prescribing of the $10,000-per-dose hemophilia medication NovoSeven. Their reasoning: It rarely saves lives and may actually cause clotting problems and strokes
New app helps docs to diagnose blood disorders
A new app debuted by Novo Nordisk last week will give physicians the ability to diagnose blood disorders more accurately and efficiently. The diabetes care giant created the app, Coags Uncomplicated,
Study: Measurements of chronic disease management savings understate case
Right now, federal policymakers are wavering over whether chronic disease management is really as great a financial deal as it's been made out to be. The CBO made things worse when it came out with a
